Results 41 to 50 of about 206,509 (284)

Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation [PDF]

open access: yes, 2014
Background This assessment updates and expands on two previous technology assessments that evaluated implantable cardioverter defibrillators (ICDs) for arrhythmias and cardiac resynchronisation therapy (CRT) for heart failure (HF).
  +232 more
core   +2 more sources

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care

open access: yesEuropean Journal of Heart Failure, 2020
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heart failure hospitalization rates and all‐cause mortality. Nevertheless,
W. Mullens   +28 more
semanticscholar   +1 more source

Electrical interventricular delay and left ventricular delay in right ventricular pacemaker pacing before upgrading to cardiac resynchronization therapy

open access: yesCurrent Directions in Biomedical Engineering, 2017
Cardiac resynchronization therapy with biventricular pacing is an established therapy for heart failure patients with sinus rhythm, reduced left ventricular ejection fraction and electrical ventricular desynchronization.
Heinke Matthias   +4 more
doaj   +1 more source

A simple prognostic index in acute heart failure [PDF]

open access: yes, 2018
Background Rapid effective triage is integral to emergency care in patients hospitalized for heart failure, to guide the type and intensity of therapy.
Cristina MOLLICA   +3 more
core   +1 more source

Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score

open access: yesEuropean Heart Journal, 2020
Aims Our aim was to develop a machine learning (ML)-based risk stratification system to predict 1-, 2-, 3-, 4-, and 5-year all-cause mortality from pre-implant parameters of patients undergoing cardiac resynchronization therapy (CRT). Methods and results
M. Tokodi   +14 more
semanticscholar   +1 more source

Data deluge from remote monitoring of cardiac implantable electronic devices and importance of clinical stratification

open access: yesHeart Rhythm O2, 2023
Background: Remote monitoring (RM) has been accepted as a standard of care for follow-up of patients with cardiac implantable electronic devices (CIEDs). However, the resulting data deluge poses major challenge to device clinics.
Danish Bawa, MD   +7 more
doaj   +1 more source

Advances in Cardiac Resynchronization Therapy [PDF]

open access: yesJournal of Innovations in Cardiac Rhythm Management, 2019
The development of cardiac resynchronization therapy (CRT) has been crucial in reducing morbidity and mortality in patients with advanced heart failure. However, a significant proportion of patients who receive CRT fail to derive significant clinical benefits from this therapy.
Miguel A. Leal, Asif Jafferani
openaire   +2 more sources

Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis [PDF]

open access: yes, 2015
BACKGROUND: Diabetes mellitus is an independent risk factor of increased morbidity and mortality in patients with heart failure. Cardiac resynchronization therapy (CRT), a pacemaker-based therapy for dyssynchronous heart failure, improves cardiac ...
Guohai Su   +11 more
core   +1 more source

Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance

open access: yesEuropean Heart Journal, 2020
Aims  Left ventricular (LV) failure in left bundle branch block is caused by loss of septal function and compensatory hyperfunction of the LV lateral wall (LW) which stimulates adverse remodelling.
J. Aalen   +18 more
semanticscholar   +1 more source

Remote Hemodynamic‐Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy

open access: yesJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Patients with recurring heart failure (HF) following cardiac resynchronization therapy fare poorly. Their management is undecided. We tested remote hemodynamic‐guided pharmacotherapy.
N. Varma   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy